# BIOCON BIOLOGICS GLOBAL PLC BIOCON BIOLOGICS GLOBAL PLC 6.67% 10/09/2029 144A

BIOCON BIOLOGICS GLOBAL PLC BIOCON BIOLOGICS GLOBAL PLC 6.67% 10/09/2029 144A is a security (CUSIP 090978AA5) tracked across SEC portfolio filings. 5 registered fund positions totaling $3.4M via N-PORT as of 2026-04-30.

## Summary

- Issuer: BIOCON BIOLOGICS GLOBAL PLC
- Class: BIOCON BIOLOGICS GLOBAL PLC 6.67% 10/09/2029 144A
- CUSIP: 090978AA5
- Asset category: DBT
- 13F holders: 0
- N-PORT fund positions: 5
- N-PORT value: $3.4M
- N-PORT report: 2026-04-30

## Top fund holders (N-PORT)

| Fund | Registrant | Value | % of fund |
| --- | --- | --- | --- |
| [Fidelity Emerging Markets Debt Central Fund](https://search.stillhousedata.com/fund/S000032745) | Fidelity Hanover Street Trust | $2.4M | 10.08% |
| Western Asset Emerging Markets Debt Fund Inc. | Western Asset Emerging Markets Debt Fund Inc. | $2.0M | 31.50% |
| [Emerging Markets Core Fund](https://search.stillhousedata.com/fund/S000054054) | Federated Hermes Core Trust | $504K | 6.27% |
| Saba Capital Income & Opportunities Fund II | Saba Capital Income & Opportunities Fund II | $-491K | -18.96% |
| Saba Capital Income & Opportunities Fund | Saba Capital Income & Opportunities Fund | $-950K | -24.11% |

## More

- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/security/090978AA5.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.